Synovus Financial Corp Incyte Corp Transaction History

Synovus Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$74.18 - $108.93 $1,928 - $2,832	-26 Closed	0 $0
Q1 2020 Apr 24, 2020	BUY	$63.18 - $85.97 $505 - $687	8 Added 44.44%	26 $2,000
Q4 2019 Feb 06, 2020	SELL	$73.04 - $95.72 $1,095 - $1,435	-15 Reduced 45.45%	18 $2,000
Q3 2019 Nov 01, 2019	BUY	$72.82 - $86.52 $2,403 - $2,855	33 New	33 $2,000
Q3 2018 Nov 01, 2018	SELL	$61.75 - $74.23 $4,137 - $4,973	-67 Closed	0 $0
Q2 2018 Aug 01, 2018	SELL	$60.85 - $83.98 $828,898 - $1.14 Million	-13,622 Reduced 99.51%	67 $4,000
Q1 2018 May 07, 2018	BUY	$83.06 - $100.98 $284,314 - $345,654	3,423 Added 33.34%	13,689 $1.14 Million
Q4 2017 Feb 09, 2018	BUY	$93.56 - $116.6 $31,810 - $39,644	340 Added 3.43%	10,266 $970,000
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $1.08 Million - $1.37 Million	9,926	9,926 $1.16 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.